220 related articles for article (PubMed ID: 34208294)
1. The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of
Momin M; Webb G
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208294
[No Abstract] [Full Text] [Related]
2. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
3. Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Ghaffar M; Orr C; Webb G
PLoS One; 2019; 14(12):e0225701. PubMed ID: 31800598
[TBL] [Abstract][Full Text] [Related]
4. A flucytosine-responsive Mbp1/Swi4-like protein, Mbs1, plays pleiotropic roles in antifungal drug resistance, stress response, and virulence of Cryptococcus neoformans.
Song MH; Lee JW; Kim MS; Yoon JK; White TC; Floyd A; Heitman J; Strain AK; Nielsen JN; Nielsen K; Bahn YS
Eukaryot Cell; 2012 Jan; 11(1):53-67. PubMed ID: 22080454
[TBL] [Abstract][Full Text] [Related]
5. Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility.
Krysan DJ; Zhai B; Beattie SR; Misel KM; Wellington M; Lin X
mBio; 2019 Jul; 10(4):. PubMed ID: 31266878
[TBL] [Abstract][Full Text] [Related]
6. Induction of signal transduction pathways related to the pathogenicity of Cryptococcus neoformans in the host environment.
Matsumoto Y; Azami S; Shiga H; Nagamachi T; Moriyama H; Yamashita Y; Yoshikawa A; Sugita T
Drug Discov Ther; 2019; 13(4):177-182. PubMed ID: 31534068
[TBL] [Abstract][Full Text] [Related]
7. Rad53- and Chk1-Dependent DNA Damage Response Pathways Cooperatively Promote Fungal Pathogenesis and Modulate Antifungal Drug Susceptibility.
Jung KW; Lee Y; Huh EY; Lee SC; Lim S; Bahn YS
mBio; 2019 Jan; 10(1):. PubMed ID: 30602579
[TBL] [Abstract][Full Text] [Related]
8. A potential of propolis on major virulence factors of Cryptococcus neoformans.
Thammasit P; Iadnut A; Mamoon K; Khacha-Ananda S; Chupradit K; Tayapiwatana C; Kasinrerk W; Tragoolpua Y; Tragoolpua K
Microb Pathog; 2018 Oct; 123():296-303. PubMed ID: 30041002
[TBL] [Abstract][Full Text] [Related]
9. Two cation transporters Ena1 and Nha1 cooperatively modulate ion homeostasis, antifungal drug resistance, and virulence of Cryptococcus neoformans via the HOG pathway.
Jung KW; Strain AK; Nielsen K; Jung KH; Bahn YS
Fungal Genet Biol; 2012 Apr; 49(4):332-45. PubMed ID: 22343280
[TBL] [Abstract][Full Text] [Related]
10. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
Liaw SJ; Wu HC; Hsueh PR
Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
[TBL] [Abstract][Full Text] [Related]
11. Virulence and antifungal susceptibility of environmental and clinical isolates of Cryptococcus neoformans from Puerto Rico.
Fromtling RA; Abruzzo GK; Ruiz A
Mycopathologia; 1989 Jun; 106(3):163-6. PubMed ID: 2682249
[TBL] [Abstract][Full Text] [Related]
12. Combatting the evolution of antifungal resistance in Cryptococcus neoformans.
Bermas A; Geddes-McAlister J
Mol Microbiol; 2020 Nov; 114(5):721-734. PubMed ID: 32697029
[TBL] [Abstract][Full Text] [Related]
13. Fungal Kinases With a Sweet Tooth: Pleiotropic Roles of Their Phosphorylated Inositol Sugar Products in the Pathogenicity of
Lev S; Li C; Desmarini D; Sorrell TC; Saiardi A; Djordjevic JT
Front Cell Infect Microbiol; 2019; 9():248. PubMed ID: 31380293
[TBL] [Abstract][Full Text] [Related]
14. The antifungal and Cryptococcus neoformans virulence attenuating activity of Pelargonium sidoides extracts.
Samie S; Trollope KM; Joubert LM; Makunga NP; Volschenk H
J Ethnopharmacol; 2019 May; 235():122-132. PubMed ID: 30738119
[TBL] [Abstract][Full Text] [Related]
15. Adenylyl-Sulfate Kinase (Met14)-Dependent Cysteine and Methionine Biosynthesis Pathways Contribute Distinctively to Pathobiological Processes in Cryptococcus neoformans.
Lee SH; Jang YB; Choi Y; Lee Y; Shin BN; Lee HS; Lee JS; Bahn YS
Microbiol Spectr; 2023 Jun; 11(3):e0068523. PubMed ID: 37036370
[TBL] [Abstract][Full Text] [Related]
16. Natural compounds from freshwater mussels disrupt fungal virulence determinants and influence fluconazole susceptibility in the presence of macrophages in
Gutierrez-Gongora D; Woods M; Prosser RS; Geddes-McAlister J
Microbiol Spectr; 2024 Mar; 12(3):e0284123. PubMed ID: 38329361
[TBL] [Abstract][Full Text] [Related]
17. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.
Rittershaus PC; Kechichian TB; Allegood JC; Merrill AH; Hennig M; Luberto C; Del Poeta M
J Clin Invest; 2006 Jun; 116(6):1651-9. PubMed ID: 16741577
[TBL] [Abstract][Full Text] [Related]
18. Disarming Fungal Pathogens:
Mayer FL; Kronstad JW
mBio; 2017 Oct; 8(5):. PubMed ID: 28974618
[TBL] [Abstract][Full Text] [Related]
19. The Role of Ceramide Synthases in the Pathogenicity of Cryptococcus neoformans.
Munshi MA; Gardin JM; Singh A; Luberto C; Rieger R; Bouklas T; Fries BC; Del Poeta M
Cell Rep; 2018 Feb; 22(6):1392-1400. PubMed ID: 29425496
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcus neoformans/Cryptococcus gattii species complex melanized by epinephrine: Increased yeast survival after amphotericin B exposure.
Brilhante RSN; Rocha MGD; Oliveira JS; Pereira-Neto WA; Guedes GMM; Cordeiro RA; Sidrim JJC; Rocha MFG; Castelo-Branco DSCM
Microb Pathog; 2020 Jun; 143():104123. PubMed ID: 32169493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
